Contreras Tania, Bravo-Soto Gonzalo, Rada Gabriel
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile.
Proyecto Epistemonikos, Santiago, Chile; Centro Evidencia UC, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Medwave. 2018 Feb 13;18(1):e7152. doi: 10.5867/medwave.2018.01.7151.
It has been suggested that cannabinoids would constitute a therapeutic alternative for patients with insomnia.
To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data of primary studies, conducted a meta-analysis and generated a summary of findings table using the GRADE approach.
We identified eight systematic reviews including three studies overall, of which two were randomized trials. We concluded it is not clear whether cannabinoids have an effect on insomnia severity or on sleep quality; that they might have no effect on sleep conciliation, sleep awakening or behavior during wakefulness, and are probably associated with frequent adverse effects.
有人提出大麻素可能为失眠患者提供一种治疗选择。
为回答这个问题,我们使用了Epistemonikos,这是最大的健康系统评价数据库,通过筛选多个信息来源进行维护,包括MEDLINE、EMBASE、Cochrane等。我们从系统评价中提取数据,重新分析了原始研究的数据,进行了荟萃分析,并使用GRADE方法生成了结果总结表。
我们确定了八项系统评价,总共包括三项研究,其中两项为随机试验。我们得出结论,尚不清楚大麻素是否对失眠严重程度或睡眠质量有影响;它们可能对睡眠调节、睡眠觉醒或清醒时的行为没有影响,并且可能与频繁的不良反应有关。